Know What's Happening in BioTech
Know What's Happening in BioTech
BioTech Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
The White House unveiled TrumpRx, a new direct‑to‑consumer website that lets Americans compare prescription drug prices and find lower‑cost options. The platform pulls real‑time pricing data from pharmacies, insurers and manufacturers, and provides discount coupons and pharmacy locators. TrumpRx is positioned as a cornerstone of the administration’s broader push to curb soaring medication costs, complementing recent legislative proposals and executive actions. After a brief delay, the site is slated to go live nationwide next week.
The blog compiles leading scientists' forecasts for aging research over the next decade, highlighting a shift from descriptive studies to therapeutic interventions. Experts anticipate rapid advances in senescent‑cell clearance, epigenetic reprogramming, multi‑omics profiling, and AI‑driven target discovery. Clinical pipelines are...
Eyepoint Pharmaceuticals' CEO Jay Duker publicly questioned Ocular Therapeutix's wet AMD drug Axpaxli during a Puerto Rico investor conference, alleging the company was withholding negative Phase 3 SOL‑1 results. Ocular is currently in a self‑imposed quiet period ahead of the pivotal...
A multinational French research team applied a Restricted Boltzmann Machine (RBM) to learn the design rules of riboswitch aptamer domains. The generative model created 476 synthetic RNA sequences, some diverging up to 40% from natural examples. High‑throughput SHAPE and DMS...
Researchers at The Hong Kong Polytechnic University have identified fatty acid‑binding protein 4 (FABP4) as a key adipocyte‑derived factor that fuels metabolic liver cancer. Using proteomics, they linked elevated FABP4 levels to tumor aggressiveness in MASLD‑related hepatocellular carcinoma. The team...
Astrocytes act as metabolic hubs, converting glucose into glycogen, lactate, and neurotransmitter precursors that sustain neuronal firing. In healthy brains they flexibly switch substrates, supporting the glutamate‑glutamine cycle and redox balance. Disease‑linked stressors—such as amyloid‑beta, APOE4, and insulin resistance—drive astrocytes...
Two detainees at the federal family detention center in Dilley, Texas tested positive for measles, prompting the Department of Homeland Security to quarantine contacts and limit movement. The outbreak occurs amid lingering vaccine skepticism and reports of unsanitary conditions within...
Bayer announced that its next‑generation factor XIa inhibitor asundexian cut ischemic stroke incidence by 26% in a pivotal Phase 3 trial for secondary stroke prevention. The study also reported a favorable safety profile, with fewer major bleeding events compared with standard anticoagulants....
Researchers at Ruhr University Bochum discovered that transient “water bridges” of hydrogen‑bonded water molecules drive the temperature‑induced collapse of the polymer PNIPAM. Using massive molecular‑dynamics simulations and a novel auditory‑analytics (sonification) approach, they visualized billions of time steps and identified...
Researchers have reengineered the AAV1 capsid by displaying short peptide motifs, dramatically improving its ability to target cochlear hair cells and supporting cells. The peptide‑display library yielded variants that achieve up to three‑fold higher transduction efficiency while requiring only a...
A new global report highlights the escalating environmental threat posed by pharmaceutical residues in water bodies, soils, and wildlife. Researchers found detectable levels of active drug compounds in rivers across North America, Europe, and Asia, often exceeding safety thresholds. The...
Researchers at Harvard's Wyss Institute and MIT have created a low‑cost, field‑deployable CRISPR‑Cas12a biosensor that detects DNA or RNA from key marine barometer species in about 40 minutes. The platform integrates a lateral‑flow strip for instrument‑free visual readout and a...
Telehealth firm Hims & Hers has launched an oral semaglutide pill priced at $49 per month, directly copying Novo Nordisk’s newly released oral Wegovy that sells for $149. Novo reports strong uptake of its product, with roughly 50,000 prescriptions filled...
Bristol Myers Squibb posted fourth‑quarter 2025 sales of $12.5 billion, topping the $12.28 billion consensus. Eliquis generated $3.4 billion, falling short of expectations, while the new schizophrenia drug Cobenfy earned $51 million, missing forecasts by 3 %. Despite the miss, BMS forecasts 10‑15 % Eliquis growth...
Addgene closed 2025 by supporting researchers in 112 countries, highlighted by a rapid plasmid shipment to Laos. The nonprofit welcomed over 500 new depositing labs and its materials featured in 9,000 publications last year. New tools such as a Developer’s...
The World Economic Forum has added ACG’s Shirwal facility to its Global Lighthouse Network, making it the first pharmaceutical packaging site to receive the honor. The plant leverages AI, machine learning, IoT and digital twins to slash defects by 71%...
Bristol Myers Squibb highlighted at least ten late‑stage data readouts slated for 2024, reigniting investor enthusiasm after a period of muted pipeline news. The readouts span oncology, immunology and rare disease programs, many of which could support new label extensions...
Hims & Hers launched a new Super Bowl commercial promoting GLP‑1 weight‑loss drugs, positioning the brand amid a surge in public interest. The ad directly calls out disparities in healthcare access, contrasting affluent consumers’ ability to afford the medication with...
A case report published in Oncoscience documents a rare instance of hyperammonemic encephalopathy triggered by 5‑fluorouracil (5‑FU) in a 63‑year‑old pancreatic‑cancer patient. Despite normal liver function tests, serum ammonia spiked during chemotherapy cycles, causing acute confusion and lethargy. Prompt discontinuation...
Researchers at Arizona State University’s Biodesign Institute have demonstrated a DNA‑nanotechnology platform that stores and encrypts data using three‑dimensional molecular shapes, read electrically via micro‑sensors and decoded with AI. This approach bypasses traditional sequencing, delivering ultra‑dense, chemically stable storage and...
Thermo Fisher Scientific announced the closure of its chemical analysis manufacturing site in Franklin, Massachusetts, citing current customer demand shifts. The shutdown will affect the plant’s workforce, adding to a wave of staffing reductions across the life‑science services sector, including...
A McGill University study published in Matrix Biology identifies plasma fibronectin, a liver‑produced protein, as a critical regulator of bone formation in male mice. Mice lacking hepatic fibronectin show marked reductions in trabecular bone mass, while female mice are unaffected,...
Hims & Hers announced it will begin selling a compounded version of Novo Nordisk's Wegovy weight‑loss injection on Thursday, just weeks after the FDA approved the brand‑name drug. The telehealth firm positions the lower‑cost alternative as a more accessible option...
Researchers from IIT and IBM have unveiled a hybrid quantum‑classical workflow that accelerates de novo genome assembly by reformulating Hamiltonian and Eulerian path problems as a Higher‑Order Binary Optimisation (HOBO) task solved with the Variational Quantum Eigensolver (VQE). The approach integrates...
The study introduces a charred Trachyparcus‑derived carbon dot (CT‑CD) linked glycyrrhizic acid (GA) hydrogel, termed CT@GA‑gel, that forms at GA concentrations below 0.5 %. The negative surface charge of CT‑CDs enables low‑dose crosslinking, yielding an injectable, self‑healing, and adhesive dressing. Enhanced...
Eisai announced an exclusive commercial license with China’s Henlius to sell the anti‑PD‑1 antibody serplulimab in Japan. The agreement gives Eisai sole rights to market the immunotherapy, positioning it alongside the company’s existing oncology portfolio. Serplulimab, a checkpoint inhibitor, is...
LimbLab is an open‑source pipeline created by EMBL Barcelona to visualise and analyse three‑dimensional embryonic limb‑bud data. The workflow cleans raw microscopy volumes, builds computational meshes, assigns developmental age, aligns samples to reference models and logs each step for reproducibility....
1/ AI won’t save sloppy science. Before you dive into deep learning, master your foundations. Here’s why basic bioinformatics still rules 🧵 https://t.co/nPbaEK3hGf
The episode frames biomanufacturing as a layer of the emerging electric tech stack, arguing that biology will become the chemical manufacturing layer that converts cheap electricity and feedstocks into high‑value molecules. It contrasts China’s systematic investment in the physical infrastructure—feedstock...
A multicenter study published in the Journal of Perinatology finds that prolonged exposure to patent ductus arteriosus (PDA) significantly increases the risk of late‑onset acute kidney injury (AKI) in infants born before 28 weeks gestation. Researchers tracked PDA duration and...
Researchers from Chiba University and partner institutions reported that functional connectome (FC) uniqueness—a measure of individual brain connectivity patterns—is markedly reduced in patients with Major Depressive Disorder (MDD). The study, using harmonized resting‑state fMRI across multiple sites, found the greatest...
Researchers at USC's Keck Medicine have launched a Phase 1 trial implanting iPSC‑derived dopaminergic neurons to treat moderate‑to‑severe Parkinson's disease. The therapy, using Kenai Therapeutics' RNDP‑001 product, is administered via stereotactic surgery into the basal ganglia of twelve participants. The FDA...
Researchers from Japan and China have created a 4D‑printed vascular stent that self‑expands at body temperature, eliminating the need for external heating. The device uses a polycaprolactone‑based shape‑memory polymer composite tuned to a 37 °C transition with diethyl phthalate as a...
Novartis announced the removal of six Phase 1 oncology candidates—including KFA115, HRO761, MGY825, and AAA802—from its pipeline and introduced two new Phase 1 assets, AMO959 for prostate cancer and GCJ904 for solid tumors. The reshuffle aligns with a strategic review aimed at...
Virginia Tech professor Robert Gourdie published a commentary in Nature Biotechnology urging policymakers to balance research integrity with a robust technology‑transfer system. He warns that overly restrictive oversight could weaken the U.S. pipeline that moves publicly funded discoveries into commercial therapies....
Researchers have introduced a paper‑based fluorescent assay that uses bioengineered red blood cells stable at room temperature to perform blood typing and antibody titer measurement. The assay combines fluorescent tagging with capillary flow on paper, delivering sensitivity and specificity above...
A recent multicenter study examined sildenafil’s effectiveness in treating pulmonary hypertension among preterm infants. The findings revealed that while some neonates experienced improved oxygenation and reduced pulmonary pressures, others showed minimal benefit or adverse hemodynamic effects. Efficacy appeared linked to...
$EIKN prices at $18/share, to raise $381m at a $972m market cap. Here's @ApexOnco on what this IPO tells us: https://t.co/OYpmTI21qI
BioSpace’s Denatureed podcast episode "Programmable RNA 2.0" spotlights the next wave of RNA therapeutics beyond the COVID‑19 mRNA vaccine success. Host Jennifer Smith‑Parker interviews Erik Digman Wiklund of Circio and Jacob Becraft of Strand Therapeutics about emerging platforms such as circular RNA...
INBRAIN Neuroelectronics announced a new rice-sized graphene BCI chip as part of its ongoing partnership with Merck. The bidirectional chip can record and stimulate neural activity, using AI-driven algorithms to decode speech signals and deliver closed-loop stimulation. Merck is shifting...
Researchers at the University of Tokyo used 3D‑printing to add a pillar‑backed layer to microneedle array patches (MAPs), preserving more live virus during fabrication. The pillar‑guided MAPs showed higher viral titers and induced protective immunity against SARS‑CoV‑2 in mice. This...
A systematic review in the Journal of Perinatology reveals that neonatal clinical trials largely omit detailed social determinants of health (SDOH) data, with race and ethnicity reported far more often than income, education, or neighborhood factors. The analysis of dozens...
Grail has partnered with telehealth firm Hims & Hers to sell its Galleri multi‑cancer blood test at a $250 discount off the $949 list price. The collaboration follows Grail’s recent filing for FDA pre‑market approval, based on interim results from...
Veeva Systems’ Aaron Bean outlines five connected engagement models for biopharma, from strategic account management to marketing‑centric approaches, to address mounting access challenges in the UK and Europe. He highlights that HCP accessibility in the UK is only 25% versus...
A new analysis of the CARDIA cohort spanning 34 years confirms that men experience premature atherosclerotic cardiovascular disease (CVD) several years earlier than women, with a 5% cumulative incidence occurring at age 50.5 versus 57.5 for women. The gap emerges...
A recent human trial of α‑ketoglutarate (AKG) supplementation failed to demonstrate measurable health benefits, prompting renewed focus on pre‑clinical evidence. New cell‑based research shows that the AKG‑TET enzymatic axis governs epigenetic reprogramming that drives or reverses cellular senescence. Down‑regulating AKG...
Abbott’s CardioMEMS HF wireless sensor has received NICE approval for routine NHS use in chronic heart‑failure patients. The tiny implant measures pulmonary artery pressure and transmits daily readings via a pillow‑embedded antenna, allowing clinicians to adjust medication remotely. Clinical trials...
Recent research highlights mitophagy—a cellular recycling process—as a promising lever in pancreatic cancer treatment. Activating the PINK1‑PARK2 pathway triggers selective mitochondrial clearance, making tumor cells more vulnerable to chemotherapy and immunotherapy. Pre‑clinical models show that combining mitophagy inducers with standard...
Researchers at Flinders University have created a nanoscale coating derived from peppermint essential oil using atmospheric‑pressure plasma polymerization. The ultra‑thin film adheres to catheter surfaces, killing E. coli and P. aeruginosa on contact while eliminating up to 90 % of reactive oxygen species...
Vertex's CRISPR‑based therapy Casgevy, approved over two years ago for sickle cell disease, has treated only about 60 patients globally. The slowdown stems from an unexpected manufacturing hurdle: centers cannot harvest enough autologous cells to produce the drug. This bottleneck...
